{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifkvfgm3apd2sg4zdka4sb3vbhdllmwfpvdlsa6cvq4tka4uhozqa",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mg6wyoi3ctn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/03/03/fda-pharma-uniqure-pfizer-intellia-china/?utm_campaign=rss",
  "publishedAt": "2026-03-03T14:28:37.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "The FDA concluded that UniQure's experimental Huntington’s treatment was not providing benefit for patients based on existing clinical data",
  "title": "STAT+: Pharmalittle: We’re reading about an FDA-UniQure feud, Pfizer’s ‘problem’ with the agency, and more",
  "updatedAt": "2026-03-03T14:28:41.000Z"
}